Noemie Lelievre

Noemie Lelievre has a wide range of work experience. From 2014 to 2022, they worked at various companies and institutions, including the University of Bergen, IGBMC, the Max Delbrück Center, the German Center for Neurodegenerative Diseases (DZNE), and Engitix Therapeutics. At the University of Bergen, they were a BSc Student working on a project involving metabolic regulation of Protein-N-Terminal Acetylation complex in yeast. At IGBMC, they were an MSc Student. At the Max Delbrück Center, they worked as a Research Assistant, and also completed their MSc studies there. At the German Center for Neurodegenerative Diseases (DZNE), they were a Technical Assistant working on a project involving the generation and evaluation of (Chimeric AutoAntibodies Receptor) CAAR-T cell therapies in autoimmune diseases. Lastly, at Engitix Therapeutics, they are currently working as a Scientist.

Noemie Lelievre obtained a Bachelor's Degree in Cellular Biology and Organism Physiology from the University of Strasbourg from 2012 to 2015. Noemie also obtained a Bachelor's Degree in Cellular Biology and Organism Physiology from the University of Bergen (UiB) from 2014 to 2015. After that, they pursued a Master's Degree in Neuroscience from the University of Strasbourg, The University of Freiburg, and the University of Basel from 2015 to 2017.